These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 16566628

  • 1. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants.
    Klier CM, Schmid-Siegel B, Schäfer MR, Lenz G, Saria A, Lee A, Zernig G.
    J Clin Psychiatry; 2006 Feb; 67(2):305-9. PubMed ID: 16566628
    [Abstract] [Full Text] [Related]

  • 2. St. John's wort (Hypericum perforatum)--is it safe during breastfeeding?
    Klier CM, Schäfer MR, Schmid-Siegel B, Lenz G, Mannel M.
    Pharmacopsychiatry; 2002 Jan; 35(1):29-30. PubMed ID: 11819157
    [Abstract] [Full Text] [Related]

  • 3. The safety of St. John's wort (Hypericum perforatum) during breastfeeding.
    Lee A, Minhas R, Matsuda N, Lam M, Ito S.
    J Clin Psychiatry; 2003 Aug; 64(8):966-8. PubMed ID: 12927015
    [Abstract] [Full Text] [Related]

  • 4. St. John's wort.
    Lawvere S, Mahoney MC.
    Am Fam Physician; 2005 Dec 01; 72(11):2249-54. PubMed ID: 16342849
    [Abstract] [Full Text] [Related]

  • 5. Current St John's wort research from mode of action to clinical efficacy.
    Müller WE.
    Pharmacol Res; 2003 Feb 01; 47(2):101-9. PubMed ID: 12543057
    [Abstract] [Full Text] [Related]

  • 6. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ.
    J Pharm Pharmacol; 2019 Jan 01; 71(1):129-138. PubMed ID: 29411879
    [Abstract] [Full Text] [Related]

  • 7. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
    Komoroski BJ, Parise RA, Egorin MJ, Strom SC, Venkataramanan R.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6972-9. PubMed ID: 16203790
    [Abstract] [Full Text] [Related]

  • 8. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J, Klejdus B, Kubán V.
    Ceska Slov Farm; 2007 Apr 01; 56(2):62-6. PubMed ID: 17619301
    [Abstract] [Full Text] [Related]

  • 9. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R, Koyabu N, Morimoto S, Shoyama Y, Ohtani H, Sawada Y.
    Drug Metab Dispos; 2005 Apr 01; 33(4):547-54. PubMed ID: 15640377
    [Abstract] [Full Text] [Related]

  • 10. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX, Venkatanarayanan N, Ho CY.
    J Affect Disord; 2017 Mar 01; 210():211-221. PubMed ID: 28064110
    [Abstract] [Full Text] [Related]

  • 11. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
    Schempp CM, Winghofer B, Lüdtke R, Simon-Haarhaus B, Schöpf E, Simon JC.
    Br J Dermatol; 2000 May 01; 142(5):979-84. PubMed ID: 10809859
    [Abstract] [Full Text] [Related]

  • 12.
    ; 2006 May 01. PubMed ID: 30000829
    [Abstract] [Full Text] [Related]

  • 13. Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes.
    Hokkanen J, Tolonen A, Mattila S, Turpeinen M.
    Eur J Pharm Sci; 2011 Feb 14; 42(3):273-84. PubMed ID: 21168483
    [Abstract] [Full Text] [Related]

  • 14. Comparison of German St. John's wort products according to hyperforin and total hypericin content.
    Wurglics M, Westerhoff K, Kaunzinger A, Wilke A, Baumeister A, Dressman J, Schubert-Zsilavecz M.
    J Am Pharm Assoc (Wash); 2001 Feb 14; 41(4):560-6. PubMed ID: 11486982
    [Abstract] [Full Text] [Related]

  • 15. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
    Zhou C, Tabb MM, Sadatrafiei A, Grün F, Sun A, Blumberg B.
    J Clin Immunol; 2004 Nov 14; 24(6):623-36. PubMed ID: 15622447
    [Abstract] [Full Text] [Related]

  • 16. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M.
    Drug Saf; 2004 Nov 14; 27(11):773-97. PubMed ID: 15350151
    [Abstract] [Full Text] [Related]

  • 17. St John's wort: Prozac from the plant kingdom.
    Di Carlo G, Borrelli F, Ernst E, Izzo AA.
    Trends Pharmacol Sci; 2001 Jun 14; 22(6):292-7. PubMed ID: 11395157
    [Abstract] [Full Text] [Related]

  • 18. St. John's wort components and the brain: uptake, concentrations reached and the mechanisms underlying pharmacological effects.
    Caccia S, Gobbi M.
    Curr Drug Metab; 2009 Nov 14; 10(9):1055-65. PubMed ID: 20214594
    [Abstract] [Full Text] [Related]

  • 19. St. John's wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells.
    Nosratabadi R, Rastin M, Sankian M, Haghmorad D, Tabasi N, Zamani S, Aghaee A, Salehipour Z, Mahmoudi M.
    J Immunotoxicol; 2016 May 14; 13(3):364-74. PubMed ID: 26634391
    [Abstract] [Full Text] [Related]

  • 20. Optimization of Light Intensity, Temperature, and Nutrients to Enhance the Bioactive Content of Hyperforin and Rutin in St. John's Wort.
    Kuo CH, Chou YC, Liao KC, Shieh CJ, Deng TS.
    Molecules; 2020 Sep 16; 25(18):. PubMed ID: 32948004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.